SG78265A1 - 22-Oxacholecalciferol derivatives and process for preparing the same - Google Patents

22-Oxacholecalciferol derivatives and process for preparing the same

Info

Publication number
SG78265A1
SG78265A1 SG1996009648A SG1996009648A SG78265A1 SG 78265 A1 SG78265 A1 SG 78265A1 SG 1996009648 A SG1996009648 A SG 1996009648A SG 1996009648 A SG1996009648 A SG 1996009648A SG 78265 A1 SG78265 A1 SG 78265A1
Authority
SG
Singapore
Prior art keywords
same
oxacholecalciferol
derivatives
preparing
hyperparathyroidism
Prior art date
Application number
SG1996009648A
Other languages
English (en)
Inventor
Hiroyoshi Watanabe
Kiyoshige Ochi
Masahiro Kato
Tetsuhiro Mikami
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of SG78265A1 publication Critical patent/SG78265A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
SG1996009648A 1991-12-18 1992-12-18 22-Oxacholecalciferol derivatives and process for preparing the same SG78265A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP36105191 1991-12-18

Publications (1)

Publication Number Publication Date
SG78265A1 true SG78265A1 (en) 2001-02-20

Family

ID=18471985

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996009648A SG78265A1 (en) 1991-12-18 1992-12-18 22-Oxacholecalciferol derivatives and process for preparing the same

Country Status (13)

Country Link
US (1) US5436401A (ko)
EP (1) EP0619304B1 (ko)
JP (1) JP3493037B2 (ko)
KR (1) KR100247214B1 (ko)
AT (1) ATE157966T1 (ko)
DE (1) DE69222183T2 (ko)
DK (1) DK0619304T3 (ko)
ES (1) ES2107650T3 (ko)
GR (1) GR3025468T3 (ko)
HK (1) HK1002729A1 (ko)
SG (1) SG78265A1 (ko)
TW (1) TW222621B (ko)
WO (1) WO1993012083A1 (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3563310D1 (en) * 1985-07-30 1988-07-21 Salzgitter Ind Method and device for the preparation of suspensions with constant indications from basic materials with variable properties
US6121469A (en) 1993-12-23 2000-09-19 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs
US6103709A (en) * 1993-12-23 2000-08-15 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
WO1995028162A1 (fr) * 1994-04-19 1995-10-26 Chugai Seiyaku Kabushiki Kaisha Medicament attenuant ou soignant le syndrome paraneoplasique
GB9607034D0 (en) * 1996-04-03 1996-06-05 Leo Pharm Prod Ltd Chemical compounds
KR20060038352A (ko) * 1996-09-03 2006-05-03 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 비타민 디 및 스테로이드 유도체들의 합성에 사용되는중간체들
GB9804861D0 (en) * 1998-03-06 1998-04-29 Res Inst Medicine Chem Chemical compounds
KR100560910B1 (ko) * 1998-07-03 2006-03-14 츄가이 세이야꾸 가부시키가이샤 광화학 반응용 자외선 조사장치 및 이를 이용한 비타민 ｄ유도체의 제조방법
DK1219599T3 (da) * 1999-08-27 2010-05-25 Hiroaki Takayama Vitamin-D-derivater som har substituenter i 2-alfa-position
US7074777B2 (en) 2000-04-19 2006-07-11 Chugai Seiyaku Kabushiki Kaisha Vitamin D derivatives
CA2411409C (en) 2000-06-15 2011-05-17 Chugai Seiyaku Kabushiki Kaisha Vitamin d derivatives
CA2425367A1 (en) * 2000-08-30 2003-04-07 Chugai Seiyaku Kabushiki Kaisha Oct formulations
WO2012122451A2 (en) 2011-03-09 2012-09-13 Teva Pharmaceutical Industries Ltd. Polymorphs of maxacalcitol and process for the preparation of maxacalcitol
CN102796134B (zh) * 2012-08-31 2015-07-01 甘肃皓天化学科技有限公司 一种马沙骨化醇中间体的制备方法
CN103508999B (zh) 2013-10-12 2015-05-13 浙江海正药业股份有限公司 马沙骨化醇的合成中间体及其制备方法和用途
CN107286067A (zh) * 2016-04-05 2017-10-24 湖南华腾制药有限公司 一种马沙骨化醇的制备方法
KR102472541B1 (ko) 2019-11-27 2022-11-30 연성정밀화학(주) 막사칼시톨의 제조방법 및 그를 위한 중간체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61140560A (ja) * 1984-12-12 1986-06-27 Chugai Pharmaceut Co Ltd ２０−オキサ−２１−ノルビタミンｄ３誘導体
JPS61267550A (ja) * 1984-12-28 1986-11-27 Chugai Pharmaceut Co Ltd ９，１０−セコ−５，７，１０（１９）−プレグナトリエン誘導体
JP3050564B2 (ja) * 1989-12-15 2000-06-12 中外製薬株式会社 新規な２２―オキサビタミンｄ誘導体

Also Published As

Publication number Publication date
EP0619304B1 (en) 1997-09-10
ATE157966T1 (de) 1997-09-15
EP0619304A4 (en) 1995-03-29
US5436401A (en) 1995-07-25
DK0619304T3 (da) 1998-02-16
DE69222183T2 (de) 1998-01-22
GR3025468T3 (en) 1998-02-27
JPH0672994A (ja) 1994-03-15
EP0619304A1 (en) 1994-10-12
HK1002729A1 (en) 1998-09-11
WO1993012083A1 (en) 1993-06-24
JP3493037B2 (ja) 2004-02-03
TW222621B (ko) 1994-04-21
KR100247214B1 (ko) 2000-03-15
KR940703807A (ko) 1994-12-12
ES2107650T3 (es) 1997-12-01
DE69222183D1 (de) 1997-10-16

Similar Documents

Publication Publication Date Title
SG78265A1 (en) 22-Oxacholecalciferol derivatives and process for preparing the same
HK1010371A1 (en) Processes for the production of 13-ether derivatives of milbemycins, and intermediates therefor
ZA200110520B (en) Pyrazole derivatives and process for producing the same, and pesticides containing the same as the active ingredient.
AU679859B2 (en) Novel compound, process for producing the same, and antitumor agent
AU747521C (en) Cycloalkene derivatives, process for producing the same, and use
HUT64944A (en) New aryl-glycide-amide derivatives and method for producing them
HUT59378A (en) Process for producing urea derivatives and pharmaceutical compositions comprising such compounds
HU910748D0 (en) New substituted amine compounds and process for producing them
ES2032416T3 (es) Procedimiento para producir derivados de fluor de vitamina d3. (reserva del art. 167.2 cpe).
YU140186A (en) Process for preparing derivatives 1,2,4-triazole-1-il buthane
GR3033386T3 (en) Vitamin d derivative and process for producing the same.
DK480389D0 (da) Antitumorstof, fremgangsmaade til dets fremstilling og anticancermiddel indeholdende stoffet
HUT59083A (en) Improved process for producing 4-methyl-sulfonyl-benzoic acid derivatives
AU3630489A (en) Novel derivatives and processes for the production thereof
HU906407D0 (en) Process for producing new inozine- and guanozine derivatives and pharmaceutical compositions containing them as active components
GB2232669A (en) Novel cyclobutane derivative and process for producing same